Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1

NCT07167966 is registered in ClinicalTrials.gov with Paul S. Aisen as lead sponsor.

NCT NCT07167966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1
Lead sponsor
Paul S. Aisen
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
November 3, 2026
Completion date
August 31, 2028
Enrollment
450 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, preclinical alzheimer's disease, prodromal alzheimer's disease